DFCM
TGTX icon

Dark Forest Capital Management’s TG Therapeutics TGTX Stock Holding History

Dark Forest Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,252
Closed -$734K – 1154
2024
Q2 		$734K Buy
+41,252
New +$658K 0.13% 164
2023
Q4 		– Sell
-172,675
Closed -$1.44M – 1040
2023
Q3 		$1.44M Buy
172,675
+114,801
+198% +$1.6M 0.11% 266
2023
Q2 		$1.44M Buy
57,874
+42,363
+273% +$1.09M 0.13% 154
2023
Q1 		$233K Buy
+15,511
New +$236K 0.06% 324
2022
Q1 		– Sell
-367
Closed -$7K – 1752
2021
Q4 		$7K Buy
+367
New +$9.53K ﹤0.01% 1067

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dark Forest Capital Management's TGTX Position: Q3 2024 in Review

Dark Forest Capital Management sold out of TG Therapeutics (TGTX) in Q3 2024, closing a stake of 41,252 shares — an estimated $734K sold.

Dark Forest Capital Management first reported a position in TGTX in Q4 2021 and held it in 5 quarters. The position peaked at $1.44M in Q3 2023. 308 funds tracked by Wall St. Rank hold TGTX as of Q3 2024.

  • Dark Forest Capital Management reported no remaining TG Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 41,252 TG Therapeutics shares in Q3 2024, an estimated $734K.
  • Dark Forest Capital Management first reported a position in TG Therapeutics in Q4 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's TG Therapeutics position peaked at $1.44M in Q3 2023.
  • 308 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.